Anti Infectives, Vol II: Antibacterials

Abstract

Antibacterial drugs have turned bacterial infections into treatable ailments rather than the life-threatening conditions they once were. But the effectiveness of many antibiotics is being reduced as more and more types of bacteria become resistant to them. Because of antibiotic resitance and other changing dynamics, knowledge of issues and trends is necessary to operate the antibacterials market.

Kalorama' s Anti-Infectives, Vol. II: Antibacterials provides extensive detail on the anti-bacterial market, including the following critical trends:

• Drug resistance and Interactions
• Antibiotic Abuse
• Antibiotic Cycling
• Addressing Market Trends
• Antibiotic Use in Agriculture
• Antibiotic Education
• Children and Bacterial Resistance
• The Elderly and Bacterial Resistance
• Compromised Individuals and Bacterial Resistance
• Screening Hospital Patients
• Side Effects of Antibiotics
• Partnerships and Alliances
• Environment and Drug Resistance
• Methicillin Resistant Staphylococcus Aureus

In this, the second volume of Kalorama Information' s Anti-Infective Markets series, the antibacterial drug market is broken down into seven general categories based on drug class:

• cephalosporins
• macrolides
• penicillins
• quinolones
• sulfonamides
• tetracyclines
• other misc. antibiotics

There is a significant trend shift occuring in the antibacterials market since Kalorama Information' s last edition in 2005. Anti-Infectives Vol. II: Antibacterials covers that shift in detail. For each marketplace segment, Market Size, Growth and Share are provided, and revenue is forecasted to 2011 are provided. Current products are discussed and new pipeline products are assessed. In total, over 100 Tables and Figures provide accessible data on this growing market, a depth of coverage unsurpassed by any competitive study.

The following companies are profiled as part of this report:

• Abbott Laboratories
• AstraZeneca
• Bayer Schering Pharma
• Cubist Pharmaceuticals
• Daiichi Sankyo
• GlaxoSmithKline
• Johnson & Johnson Group
• King Pharmaceuticals
• Merck & Company, Inc.
• Pfizer, Inc.
• Roche
• Sanofi-Aventis
• Wyeth